BioPAT® Process Insights Software | Simplified, Predictive Bioreactor Scale up and Scale down
The ability to scale a cell culture effectively and efficiently from lab to manufacturing is critical to maximizing productivity and reducing risk at each transfer. A poorly scaled process can lead to run failures and overall delays to the time to market that can cost $millions per month.
In this on-demand webinar, Sinyee Yau-Rose, Product Manager, will introduce BioPAT® Process Insights, a new software product for predictive scale conversion across supported Sartorius bioreactor scales. BioPAT® Process Insights contains exclusive characterized data and a novel, risk-based approach to scaling that enables multiple scaling approaches to be considered across multiple scales simultaneously from the start of the scaling journey. David Seales, Product Specialist for Ambr®, will discuss how BioPAT® Process Insights works and how it can simplify the scaling process.
Learn about a new standalone software application that can simplify and de-risk scaling
Learn how BioPAT® Process Insights can address scaling challenges and help ease scaling
Discover how scaling between Ambr® and Biostat® STR bioreactors can be optimized
Meet Our Experts:
Sinyee Yau-Rose, PhD
Product Manager – Ambr® software applications
Sinyee holds a PhD and a MEng degree in Biochemical Engineering from UCL and joined TAP Biosystems (acquired by Sartorius in 2013) in 2010 as a Bioprocess Product Specialist for Ambr®. Sinyee became the Global Product Manager for Ambr® software applications in 2018.
David Seales
Product Specialist - Ambr® Technologies
David is a Product Specialist for Ambr® technologies supporting the EMEA region. He holds a degree in Biomedical Sciences from the University of Northumbria.